Localization of multiple pleiotropic genes for lipoprotein metabolism in baboons

Journal of Lipid Research

Volumn 50, Issue 7, 2009, Pages 1420-1428

  Rainwater, David L ^a   Cox, Laura A ^a,b   Rogers, Jeffrey ^a,b   VandeBerg, John L ^a,b   Mahamey, MichaeL C ^a,b  

^a SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Genetic; Linkage analysis; Primate; Quantitative trait locus

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BABOON; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHROMOSOME 1; CHROMOSOME 12Q; CHROMOSOME 1P; EXON; GENE CLUSTER; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE MAPPING; GENE REPLICATION; HUMAN; LINKAGE ANALYSIS; LIPID DIET; LIPOPROTEIN METABOLISM; MICROSATELLITE MARKER; NONHUMAN; PEDIGREE; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS;

ANIMALS; CHROMOSOMES, MAMMALIAN; DIET; GENE EXPRESSION REGULATION; GENETIC LINKAGE; GENOTYPE; HUMANS; LIPID METABOLISM; LIPIDS; LIPOPROTEINS; LOD SCORE; MULTIGENE FAMILY; PAPIO; QUANTITATIVE TRAIT LOCI;

EID: 67650547238     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800583-JLR200     Document Type: Article

References (51)

1. Singh, A. T. K., D. L. Rainwater, C. M. Kammerer, R. M. Sharp, M. Poushesh, W. R. Shelledy, and J. L. VandeBerg. 1996. Dietary and genetic effects on LDL size measures in baboons. Arterioscler. Thromb. Vasc. Biol. 16: 1448-1453.
2. Cheng, M-L., S. C. Woodford, J. L. Hilburn, and J. L. VandeBerg. 1986. A novel system for storage of sera frozen in small aliquots. J. Biochem. Biophys. Methods. 13: 47-51.
3. Rainwater, D. L., C. M. Kammerer, K. D. Carey, B. Dyke, J. F. VandeBerg, W. R. Shelledy, P. H. Moore, Jr., M. C. Mahaney, H. C. McGill, Jr., and J. L. VandeBerg. 2002. Genetic determination of HDL variation and response to diet in baboons. Atherosclerosis. 161: 335-343.
4. Lipid Research Clinics Program. 1974. Manual of Laboratory Operations. Vol. 1. Lipid and Lipoprotein Analysis. (DHEW Publ. No. (NIH) 75-628). US Government Printing Office, Washington D.C.
5. Rainwater, D. L., C. M. Kammerer, L. A. Cox, J. Rogers, K. D. Carey, B. Dyke, M. C. Mahaney, H. C. McGill, Jr., and J. L. VandeBerg. 2002. A major gene influences variation in large HDL particles and their response to diet in baboons. Atherosclerosis. 163: 241-248.
6. Kammerer, C. M., D. L. Rainwater, L. A. Cox, J. L. Schneider, M. C. Mahaney, J. Rogers, and J. L. VandeBerg. 2002. Locus controlling LDL cholesterol response to dietary cholesterol is on baboon homologue of human chromosome 6. Arterioscler. Thromb. Vasc. Biol. 22: 1720-1725.
7. Rainwater, D. L., C. M. Kammerer, and J. L. VandeBerg. 1999. Evidence that multiple genes influence baseline concentrations and diet response of Lp(a) in baboons. Arterioscler. Thromb. Vasc. Biol. 19: 2696-2700.
8. Rainwater, D. L., P. H. Moore, Jr., W. R. Shelledy, T. D. Dyer, and S. H. Slifer. 1997. Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins. J. Lipid Res. 38: 1261-1266.
9. Rainwater, D. L., D. W. Andres, A. L. Ford, W. F. Lowe, P. J. Blanche, and R. M. Krauss. 1992. Production of polyacrylamide gradient gels for the electrophoretic resolution of lipoproteins. J. Lipid Res. 33: 1876-1881.
10. Rainwater, D. L., C. M. Kammerer, M-L. Cheng, M. L. Sparks, and J. L. VandeBerg. 1992. Distribution of specific apolipoproteins detected by immunoblotting of baboon lipoproteins resolved by polyacrylamide gradient gel electrophoresis. Biochem. Genet. 30: 143-158.
11. Hsueh, W-C., B. D. Mitchell, J. E. Hixson, and D. L. Rainwater. 2000. Effects of the apoE polymorphism on plasma lipoproteins in Mexican Americans. Ann. Epidemiol. 10: 524-531.
12. Vinson, A., M. C. Mahaney, L. A. Cox, J. Rogers, J. L. VandeBerg, and D. L. Rainwater. 2008. A pleiotropic QTL on 2p influences serum Lp-PLA2 activity and LDL cholesterol concentration in a baboon model for the genetics of atherosclerosis risk factors. Atherosclerosis. 196: 667-673.
13. Rainwater, D. L., M. C. Mahaney, X. L. Wang, J. Rogers, L. A. Cox, and J. L. VandeBerg. 2005. Determinants of variation in serum paraoxonase enzyme activity in baboons. J. Lipid Res. 46: 1450-1456.
14. Rogers, J., M. C. Mahaney, S. M. Witte, S. Nair, D. Newman, S. Wedel, L. A. Rodriguez, K. S. Rice, S. H. Slifer, A. Perelygin, et al. 2000. A genetic linkage map of the baboon (Papio hamadryas) genome based on human microsatellite polymorphisms. Genomics. 67: 237-247.
15. Cox, L. A., M. C. Mahaney, J. L. VandeBerg, and J. Rogers. 2006. A second-generation genetic linkage map of the baboon (Papio hamadryas) genome. Genomics. 88: 274-281.
16. Almasy, L., and J. Blangero. 1998. Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 62: 1198-1211.
17. Heath, S. C., G. L. Snow, E. A. Thompson, C. Tseng, and E. M. Wijsman. 1997. MCMC segregation and linkage analysis. Genet. Epidemiol. 14: 1011-1016.
18. Ott, J. 1998. Analysis of Human Genetic Linkage. The Johns Hopkins University Press, Baltimore, MD.
19. Feingold, E., P. O. Brown, and D. Siegmund. 1993. Gaussian models for genetic linkage analysis using complete high- resolution maps of identity by descent. Am. J. Hum. Genet. 53: 234-251.
20. Williams, J. T., E. P. Van, L. Almasy, and J. Blangero. 1999. Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. I. Likelihood formulation and simulation results. Am. J. Hum. Genet. 65: 1134-1147.
21. Almasy, L., T. D. Dyer, and J. Blangero. 1997. Bivariate quantitative trait linkage analysis: pleiotropy versus co-incident linkages. Genet. Epidemiol. 14: 953-958.
22. Cox, L. A., S. Birnbaum, M. C. Mahaney, D. L. Rainwater, J. T. Williams, and J. L. VandeBerg. 2007. Identification of promoter variants in baboon endothelial lipase that regulate high-density lipoprotein cholesterol levels. Circulation. 116: 1185-1195.
23. Kent, W. J., C. W. Sugnet, T. S. Furey, K. M. Roskin, T. H. Pringle, A. M. Zahler, and D. Haussler. 2002. The human genome browser at UCSC. Genome Res. 12: 996-1006.
24. Mahaney, M. C., J. Blangero, D. L. Rainwater, G. E. Mott, A. G. Comuzzie, J. W. MacCluer, and J. L. VandeBerg. 1999. Pleiotropy and genotype by diet interaction in a baboon model for atherosclerosis - A multivariate quantitative genetic analysis of HDL subfractions in two dietary environments. Arterioscler. Thromb. Vasc. Biol. 19: 1134-1141.
25. Rainwater, D. L., C. M. Kammerer, M. C. Mahaney, J. Rogers, L. A. Cox, J. L. Schneider, and J. L. VandeBerg. 2003. Localization of genes that control LDL size fractions in baboons. Atherosclerosis. 168: 15-22.
26. Vinson, A., M. C. Mahaney, V. P. Diego, L. A. Cox, J. Rogers, J. L. VandeBerg, and D. L. Rainwater. 2008. Genotype-by-diet effects on co-variation in Lp-PLA2 activity and LDL cholesterol concentration in baboons fed an atherogenic diet. J. Lipid Res. 49: 1295-1302.
27. Rainwater, D. L., G. S. Manis, and J. L. VandeBerg. 1989. Hereditary and dietary effects on apolipoprotein[a] isoforms and Lp[a] in baboons. J. Lipid Res. 30: 549-558.
28. Hixson, J. E., M. L. Britten, G. S. Manis, and D. L. Rainwater. 1989. Apolipoprotein(a) (apo(a)) glycoprotein isoforms result from size differences in apo(a) mRNA in baboons. J. Biol. Chem. 264: 6013-6016.
29. Boerwinkle, E., C. C. Leffert, J. Lin, C. Lackner, G. Chiesa, and H. H. Hobbs. 1992. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J. Clin. Invest. 90: 52-60.
30. Costa, L. G., T. B. Cole, G. P. Jarvik, and C. E. Furlong. 2003. Functional genomics of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu. Rev. Med. 54: 371-392.
31. Deakin, S. P., and R. W. James. 2004. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin. Sci. (Lond.). 107: 435-447.
32. Li, H. L., D. P. Liu, and C. C. Liang. 2003. Paraoxonase gene polymorphisms, oxidative stress, and diseases. J. Mol. Med. 81: 766-779.
33. Rainwater, D. L., S. Rutherford, T. D. Dyer, E. D. Rainwater, S. A. Cole, J. L. VandeBerg, L. Almasy, J. Blangero, J. W. MacCluer, and M. C. Mahaney. 2009. Determinants of variation in human serum paraoxonase activity. Heredity. 102: 147-154.
34. Karolchik, D., A. S. Hinrichs, T. S. Furey, K. M. Roskin, C. W. Sugnet, D. Haussler, and W. J. Kent. 2004. The UCSC Table Browser data retrieval tool. Nucleic Acids Res. 32: D493-D496.
35. May, P., J. Herz, and H. H. Bock. 2005. Molecular mechanisms of lipoprotein receptor signalling. Cell. Mol. Life Sci. 62: 2325-2338.
36. Schroeder, F., B. P. Atshaves, A. L. McIntosh, A. M. Gallegos, S. M. Storey, R. D. Parr, J. R. Jefferson, J. M. Ball, and A. B. Kier. 2007. Sterol carrier protein-2: new roles in regulating lipid rafts and signaling. Biochim. Biophys. Acta. 1771: 700-718.
37. Lambert, G. 2007. Unravelling the functional significance of PCSK9. Curr. Opin. Lipidol. 18: 304-309.
38. Lambert, G., N. Ancellin, F. Charlton, D. Comas, J. Pilot, A. Keech, S. Patel, D. R. Sullivan, J. S. Cohn, K. A. Rye, et al. 2008. Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment. Clin. Chem. 54: 1038-1045.
39. Maxwell, K. N., R. E. Soccio, E. M. Duncan, E. Sehayek, and J. L. Breslow. 2003. Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. J. Lipid Res. 44: 2109-2119.
40. Willer, C. J., S. Sanna, A. U. Jackson, A. Scuteri, L. L. Bonnycastle, R. Clarke, S. C. Heath, N. J. Timpson, S. S. Najjar, H. M. Stringham, et al. 2008. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40: 161-169.
41. Kooner, J. S., J. C. Chambers, C. A. Aguilar-Salinas, D. A. Hinds, C. L. Hyde, G. R. Warnes, F. J. Gomez Perez, K. A. Frazer, P. Elliott, J. Scott, et al. 2008. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat. Genet. 40: 149-151.
42. Sandhu, M. S., D. M. Waterworth, S. L. Debenham, E. Wheeler, K. Papadakis, J. H. Zhao, K. Song, X. Yuan, T. Johnson, S. Ashford, et al. 2008. LDL-cholesterol concentrations: a genome-wide association study. Lancet. 371: 483-491.
43. Kathiresan, S., O. Melander, C. Guiducci, A. Surti, N. P. Burtt, M. J. Rieder, G. M. Cooper, C. Roos, B. F. Voight, A. S. Havulinna, et al. 2008. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40: 189-197.
44. Kathiresan, S., O. Melander, D. Anevski, C. Guiducci, N. P. Burtt, C. Roos, J. N. Hirschhorn, G. Berglund, B. Hedblad, L. Groop, et al. 2008. Polymorphisms associated with cholesterol and risk of cardiovascular events. N. Engl. J. Med. 358: 1240-1249.
45. May, P., E. Woldt, R. L. Matz, and P. Boucher. 2007. The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann. Med. 39: 219-228.
46. Llorente-Cortes, V., and L. Badimon. 2005. LDL receptor-related protein and the vascular wall: implications for atherothrombosis. Arterioscler. Thromb. Vasc. Biol. 25: 497-504.
47. Paromov, V. M., and R. E. Morton. 2003. Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP). J. Biol. Chem. 278: 40859-40866.
48. He, Y., D. J. Greene, M. Kinter, and R. E. Morton. 2008. Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complex. J. Lipid Res. 49: 1529-1537.
49. Rudel, L. L., R. G. Lee, and P. Parini. 2005. ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 25: 1112-1118.
50. Rudel, L. L., M. Davis, J. Sawyer, R. Shah, and J. Wallace. 2002. Primates highly responsive to dietary cholesterol up-regulate hepatic ACAT2, and less responsive primates do not. J. Biol. Chem. 277: 31401-31406.
51. He, X., Y. Lu, N. Saha, H. Yang, and C. K. Heng. 2005. Acyl-CoA: cholesterol acyltransferase-2 gene polymorphisms and their association with plasma lipids and coronary artery disease risks. Hum. Genet. 118: 393-403.